Summit Trail Advisors’s Innoviva INVA Stock Holding History

Summit Trail Advisors’s Portfolio INVA Stock Details INVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-18	Closed	–	–	1038
2017 Q4	$0	Buy	+18	New	+$240	﹤0.01%	2032

Other funds holding INVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Summit Trail Advisors's INVA Position: Q1 2018 in Review

Summit Trail Advisors sold out of Innoviva (INVA) in Q1 2018, closing a stake of 18 shares.

Summit Trail Advisors first reported a position in INVA in Q4 2017 and held it in 1 quarter. The position peaked at $0 in Q4 2017. 223 funds tracked by Wall St. Rank hold INVA as of Q1 2018.

Summit Trail Advisors reported no remaining Innoviva position as of Q1 2018 after selling out during the quarter.
Summit Trail Advisors sold 18 Innoviva shares in Q1 2018.
Summit Trail Advisors first reported a position in Innoviva in Q4 2017 and held it in 1 quarter.
Summit Trail Advisors's Innoviva position peaked at $0 in Q4 2017.
223 funds tracked by Wall St. Rank held Innoviva as of Q1 2018.

Based on Summit Trail Advisors's 13F filing for Q1 2018, filed 21 May 2018.